The Prognostic Value of Electrocardiographic Estimation of Left Ventricular Hypertrophy in Dialysis Patients
| Autor: | Alina Stefan, Laura-Dumitriţa Buimistriuc, Silvia Badarau, Philip A. Kalra, Darren Green, Adrian Covic |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
medicine.medical_specialty
medicine.diagnostic_test business.industry Proportional hazards model medicine.medical_treatment Retrospective cohort study General Medicine Left ventricular hypertrophy medicine.disease Physiology (medical) Internal medicine Predictive value of tests medicine Cardiology cardiovascular diseases Cardiology and Cardiovascular Medicine business Electrocardiography Survival analysis Dialysis Cohort study |
| Zdroj: | Annals of Noninvasive Electrocardiology. 18:188-198 |
| ISSN: | 1082-720X |
| Popis: | Background: Left ventricular hypertrophy (LVH) is associated with poor cardiovascular outcome in CKD. Electrocardiogram (ECG) is low-cost but infrequently used to assess presence of LVH in dialysis patients. The aim of this study was to establish which ECG-determined LVH method is most sensitive in dialysis patients, and also most predictive of death. Methods: This was a longitudinal observational study in dialysis patients from a single center, undergoing interval ECGs. Fourteen methods of ECG LVH assessment were compared. Survival was also compared between four LVH evolutionary categories: persistent LVH; new LVH; LVH regression; and no LVH. Results: The study included 418 dialysis patients (46.3% women, mean age 51 years, mean follow up 67 months, 76 deaths, 37 cardiovascular deaths). LVH prevalence varied according to method (range 13.4–41.9%). No measurement predicted all-cause mortality. After Cox regression, there was an independent association between LVH and cardiovascular mortality using Novacode (HR = 3.04; 95% [CI] = 1.11–8.28, P < 0.05), but not with other methods. Patients with persistent ECG changes of LVH had increased risk of cardiovascular mortality compared to other LVH evolutionary categories (P < 0.044). Conclusions: ECG scoring of LVH can be predictive of cardiovascular mortality. The Novacode method, based on repolarization abnormalities, is a better predictor than standard ECG techniques that are based on voltage criteria. Novacode LVH estimation at dialysis initiation may prove to be a noninvasive and cost-effective bedside tool for cardiovascular risk stratification in patients receiving dialysis. Ann Noninvasive Electrocardiol 2012;00(00):1–11 dialysis; left ventricular hypertrophy; cardiovascular; survival; ECG |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|